The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the life science realm.
…
continue reading
1
The World in a Grain of Sand: CG Oncology
43:43
43:43
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
43:43
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Cain McClary and Phil Grayeski discuss CG Oncology, the first biotech IPO of 2024. We dive into: The various subtypes of bladder cancer, and one of the most uniq…
…
continue reading
1
The World in a Grain of Sand: Verve Therapeutics
41:27
41:27
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
41:27
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Ketan Yerneni and Mack Healy discuss Verve Therapeutics, a gene editing biotech tackling one of the most common chronic diseases: cardiovascular disease. We dive…
…
continue reading
1
The World in a Grain of Sand: Schrödinger
42:16
42:16
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
42:16
KdT Ventures presents The World in a Grain of Sand, where we break down an S1 from a recent biotech IPO and share insights on the science, business models, and financials. In this episode, Patrick Malone and Mack Healy discuss the biopharma software juggernaut, Schrödinger. We dive into: Schrödinger's biophysics-based drug discovery platform, and t…
…
continue reading
1
The World in a Grain of Sand: Amylyx Pharmaceuticals
34:33
34:33
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
34:33
KdT Ventures Partners, Mack Healy & Rima Chakrabarti take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This episode, Amylyx Pharmaceuticals, a neuro biotech founded in a dorm room by two scrappy Brown undergrads. We discuss: the mechanism of action of Amylyx’s lead disease-modify…
…
continue reading
1
The World in a Grain of Sand: Codiak BioSciences
37:15
37:15
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
37:15
KdT Ventures Partners, Mack Healy & Phil Grayeski take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Codiak BioSciences.
…
continue reading
1
The World in a Grain of Sand: Royalty Pharma
39:49
39:49
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
39:49
KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Royalty Pharma.
…
continue reading
1
The World in a Grain of Sand: Sana Biotechnology
37:03
37:03
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
37:03
KdT Ventures Partners, Mack Healy & Phil Grayeski take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Sana Biotechnology.
…
continue reading
1
The World in a Grain of Sand: Editas
39:05
39:05
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
39:05
KdT Ventures Partners, Mack Healy & Cain McClary take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Editas.
…
continue reading
1
The World in a Grain of Sand: Century Therapeutics
41:41
41:41
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
41:41
KdT Ventures Partners, Mack Healy & Rima Chakrabarti take a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Century Therapeutics.
…
continue reading
1
The World In A Grain of Sand: Taysha
30:24
30:24
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
30:24
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that has or is hoping to go public within the biology realm. This month, Taysha GTx
…
continue reading
1
The World In A Grain of Sand: Atai
40:19
40:19
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
40:19
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Atai
…
continue reading
1
The World In A Grain of Sand: Recursion Pharmaceuticals
40:25
40:25
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
40:25
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, Recursion Pharmaceuticals.
…
continue reading
1
The World In A Grain of Sand: AbCellera
42:55
42:55
Main Kemudian
Main Kemudian
Senarai
Suka
Disukai
42:55
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the biology realm. This month, AbCellera.
…
continue reading